The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Total metabolic tumor volume for predicting cytokine release syndrome and treatment response in patients receiving bispecific antibodies for B-cell lymphoma.
 
Xi Yang
No Relationships to Disclose
 
Shelbie Cingoranelli
No Relationships to Disclose
 
Tycel Phillips
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca; Bayer; BeiGene; BMS GmbH & Co. KG; Epizyme; Genentech; Genmab; Gilead Sciences; Incyte; Janssen; Kite/Gilead; Lilly; Merck; Pharmacyclics
Research Funding - Abbvie; Genentech
Other Relationship - Leukemia and Lymphoma Society
 
Iman Ahmed
Consulting or Advisory Role - GlaxoSmithKline; Pfizer
 
Victoria Nachar
Consulting or Advisory Role - BeiGene; GlaxoSmithKline
 
Jonathan Weiss
Honoraria - Targeted Oncology
Research Funding - Bristol Myers Squibb Foundation; Merck
Travel, Accommodations, Expenses - Roche/Genentech
 
Shannon Carty
No Relationships to Disclose
 
Ryan Wilcox
Research Funding - Corvus Pharmaceuticals (Inst); Merck (Inst); SciTech Development LLC (Inst); Sobi (Inst)
 
Benjamin Viglianti
No Relationships to Disclose
 
Yasmin Karimi
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Genmab; Merck; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genmab (Inst); Loxo/Lilly (Inst); Merck (Inst); Roche/Genentech (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Roche/Genentech